NurExone Biologic (NRX.V) Q4 2024 Earnings

Nov 27Confirmed
Q2 2023
Q2 2024
Q3 2024
Q4 2024
-0.05
-0.04
-0.03
-0.02

Details

Expected EPS
-0.0420816
Actual EPS
-0.0280544
Surprise EPS
0.01
Surprise Percent
+33.33%

Description

⁨NurExone Biologic⁩ (⁦NRX.V⁩) has reported earnings of ⁦-0.0280544⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts